Matches in Wikidata for { <http://www.wikidata.org/entity/Q37100817> ?p ?o ?g. }
- Q37100817 description "article científic" @default.
- Q37100817 description "article scientifique" @default.
- Q37100817 description "articolo scientifico" @default.
- Q37100817 description "artigo científico" @default.
- Q37100817 description "artículu científicu espublizáu en 2013" @default.
- Q37100817 description "bilimsel makale" @default.
- Q37100817 description "scientific article published on 27 June 2013" @default.
- Q37100817 description "vedecký článok" @default.
- Q37100817 description "vetenskaplig artikel" @default.
- Q37100817 description "videnskabelig artikel" @default.
- Q37100817 description "vědecký článek" @default.
- Q37100817 description "wetenschappelijk artikel" @default.
- Q37100817 description "wissenschaftlicher Artikel" @default.
- Q37100817 description "наукова стаття, опублікована в червні 2013" @default.
- Q37100817 description "научни чланак" @default.
- Q37100817 description "مقالة علمية نشرت في 27 يونيو 2013" @default.
- Q37100817 name "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 name "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 name "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 type Item @default.
- Q37100817 label "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 label "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 label "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 prefLabel "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 prefLabel "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 prefLabel "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 P1433 Q37100817-457BF085-AC31-4749-A4FE-D0216BAA5446 @default.
- Q37100817 P1476 Q37100817-62CC553B-0743-4F39-B48C-3F64D17C5234 @default.
- Q37100817 P2093 Q37100817-2B2E6911-8ACB-4256-844B-A6DE10580C81 @default.
- Q37100817 P2093 Q37100817-46E61D94-C49F-40D4-8853-30382FCB8A9B @default.
- Q37100817 P2093 Q37100817-558CD1FD-36E2-47D1-84E7-6B28D4D36DAB @default.
- Q37100817 P2093 Q37100817-8099E679-B2D7-4ECC-AF17-0509D2E8C8B9 @default.
- Q37100817 P2093 Q37100817-87423F94-9C36-4B1A-8C28-F15DB2AE17CA @default.
- Q37100817 P2093 Q37100817-92909064-17B2-406A-8051-4A311B77D290 @default.
- Q37100817 P2093 Q37100817-9A654B13-C823-4AC4-A2B9-8D784A360EA6 @default.
- Q37100817 P2093 Q37100817-B2C4763E-DD07-445A-B85C-A275394FDA3C @default.
- Q37100817 P2093 Q37100817-DC52964B-2DF3-4045-AE3E-D863BD63B052 @default.
- Q37100817 P2093 Q37100817-EB59A2FD-1D55-4973-A602-EB32951BECAC @default.
- Q37100817 P2860 Q37100817-054AF554-53B5-4D54-97A9-F9F24D227543 @default.
- Q37100817 P2860 Q37100817-3738838F-F73F-4521-89E4-13B5F6F235AC @default.
- Q37100817 P2860 Q37100817-52CF2B6F-F9F7-4F02-B8FB-DD8C5C75A864 @default.
- Q37100817 P2860 Q37100817-5EADF46C-DE46-44F8-92FE-8C94CC0D505B @default.
- Q37100817 P2860 Q37100817-74AA43CC-1F56-4795-959C-04434B33D108 @default.
- Q37100817 P2860 Q37100817-9217B755-3FB2-4A4C-9431-16B1268E9CFD @default.
- Q37100817 P2860 Q37100817-AD49C88A-9B64-478C-9F69-88F7B3102AB9 @default.
- Q37100817 P2860 Q37100817-BB73172E-9507-44F7-978B-420AEA5EB580 @default.
- Q37100817 P2860 Q37100817-C3BF10E9-271E-485F-903A-CDB412FADA08 @default.
- Q37100817 P2860 Q37100817-CDE3DCCF-8A9A-4686-BE31-BECD7EFEF294 @default.
- Q37100817 P2860 Q37100817-F94DAD77-2829-4286-9342-24746B7F6420 @default.
- Q37100817 P2860 Q37100817-FA5E0530-3314-49BE-9A95-3499D5F333A1 @default.
- Q37100817 P2860 Q37100817-FE2F2EC6-DF25-4D53-A8A5-B3AAD5EDDF33 @default.
- Q37100817 P304 Q37100817-6F7C3EA8-A449-4937-9DBE-CB34B1C92799 @default.
- Q37100817 P31 Q37100817-BC57B33A-7CEA-4207-95AD-5389D8D465B4 @default.
- Q37100817 P356 Q37100817-DC5D5F19-5527-460A-B9E5-CCD9F020881A @default.
- Q37100817 P407 Q37100817-85B691EC-E1F7-4995-A9FE-AD5173EC3A63 @default.
- Q37100817 P433 Q37100817-F05674DF-38F6-42D5-8FD6-23BBED3FE384 @default.
- Q37100817 P478 Q37100817-7B93FE43-FB0D-4AF5-8EDF-225D48BD8E5C @default.
- Q37100817 P50 Q37100817-DC14FF4B-FA19-41BB-81F6-47D7084BC603 @default.
- Q37100817 P577 Q37100817-B333AE16-F98D-4D05-B943-E6166F14CF04 @default.
- Q37100817 P698 Q37100817-3CD2E57C-1E86-4A29-8313-3FF82621EC2B @default.
- Q37100817 P921 Q37100817-040F56C8-A26C-428F-AD32-03CF41228369 @default.
- Q37100817 P921 Q37100817-171C35DF-79E5-4B9F-AACD-11E858B8D070 @default.
- Q37100817 P921 Q37100817-A8899B42-C9D9-40CD-AFBD-189B08DDF91A @default.
- Q37100817 P921 Q37100817-ED2B1494-2B79-4C9B-BFAC-61ED055E4AE6 @default.
- Q37100817 P932 Q37100817-458E8794-3EE1-48F7-8FC2-ECCF89108CB9 @default.
- Q37100817 P356 BJH.12434 @default.
- Q37100817 P698 23802659 @default.
- Q37100817 P1433 Q4970200 @default.
- Q37100817 P1476 "Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report" @default.
- Q37100817 P2093 "Bruce Shiramizu" @default.
- Q37100817 P2093 "Lauren Harrison" @default.
- Q37100817 P2093 "Lisa Giulino-Roth" @default.
- Q37100817 P2093 "Lynette Smith" @default.
- Q37100817 P2093 "Matthew J Barth" @default.
- Q37100817 P2093 "Mitchell S Cairo" @default.
- Q37100817 P2093 "Sherrie Perkins" @default.
- Q37100817 P2093 "Stanton Goldman" @default.
- Q37100817 P2093 "Thomas G Gross" @default.
- Q37100817 P2093 "Warren Sanger" @default.
- Q37100817 P2860 Q33369574 @default.
- Q37100817 P2860 Q34440364 @default.
- Q37100817 P2860 Q35750976 @default.
- Q37100817 P2860 Q35750990 @default.
- Q37100817 P2860 Q35963027 @default.
- Q37100817 P2860 Q36216264 @default.
- Q37100817 P2860 Q39912811 @default.
- Q37100817 P2860 Q40357320 @default.
- Q37100817 P2860 Q40381373 @default.
- Q37100817 P2860 Q43864036 @default.
- Q37100817 P2860 Q47884003 @default.
- Q37100817 P2860 Q83172419 @default.
- Q37100817 P2860 Q84532763 @default.
- Q37100817 P304 "678-683" @default.
- Q37100817 P31 Q13442814 @default.
- Q37100817 P356 "10.1111/BJH.12434" @default.
- Q37100817 P407 Q1860 @default.
- Q37100817 P433 "5" @default.
- Q37100817 P478 "162" @default.
- Q37100817 P50 Q42765048 @default.
- Q37100817 P577 "2013-06-27T00:00:00Z" @default.